Cleared Traditional

K192525 - 087 Balloon Guide Catheter System

K192525 is the FDA 510(k) clearance for 087 Balloon Guide Catheter System by Q'Apel Medical, LLC. It is a Class 2 Neurology device (product code DQY) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
48d
Days
Class 2
Risk

K192525 is an FDA 510(k) clearance for the 087 Balloon Guide Catheter System. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Q'Apel Medical, LLC (Santa Monica, US). The FDA issued a Cleared decision on October 31, 2019 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Q'Apel Medical, LLC devices

Submission Details

510(k) Number K192525 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2019
Decision Date October 31, 2019
Days to Decision 48 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 148d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Lakeshore Medical Device Consulting, LLC
Michele Lucey

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K192525.
PG Pro Microcatheter
K192625 · MicroVention, Inc. A TERUMO Group Company · Nov 2019
Selectra Catheters, Selectra Accessory Kit, Selectra Slitter Tool
K192996 · Biotronik, Inc. · Nov 2019
CERENOVUS Large Bore Catheter
K191237 · Codman & Shurtleff, Inc. · Nov 2019
Medtronic 6F Taiga Guiding Catheter
K192296 · Medtronic Vascular · Sep 2019
SelectFlex 072 Neurovascular Access System
K191664 · Q'Apel Medical · Aug 2019
Turnpike Catheter
K191560 · Vascular Solutions, LLC · Aug 2019